PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL: A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

PDB32 A LONG-TERM Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 MG Versus Once-Daily Empagliflozin 25 MG

Value in Health ◽

10.1016/j.jval.2020.08.629 ◽

2020 ◽

Vol 23 ◽

pp. S511

Author(s):

N. Hallén ◽

D. Carvalho ◽

C. Costa ◽

B. Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Once Daily ◽

Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.13318 ◽

2018 ◽

Vol 20 (8) ◽

pp. 1921-1927 ◽

Cited By ~ 3

Author(s):

Anthony H. Barnett ◽

Simon Arnoldini ◽

Barnaby Hunt ◽

Gowri Subramanian ◽

Christina Stentoft Hoxer

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

The Uk

Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain

Value in Health ◽

10.1016/j.jval.2016.03.1714 ◽

2016 ◽

Vol 19 (3) ◽

pp. A99

Author(s):

M Prades ◽

L Lizan ◽

B Hunt ◽

A Ramirez de Arellano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Basal Insulin ◽

PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN: A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC

Value in Health ◽

10.1016/j.jval.2018.09.779 ◽

2018 ◽

Vol 21 ◽

pp. S130-S131

Author(s):

M. Russel-Szymczyk ◽

W. Parekh ◽

K. Rychna ◽

J. Pöhlmann ◽

B. Hunt

Keyword(s):

Type 2 Diabetes ◽

Czech Republic ◽

Cost Effectiveness ◽

Basal Insulin ◽

The Czech Republic ◽

The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

Advances in Therapy ◽

10.1007/s12325-019-00965-y ◽

2019 ◽

Vol 36 (8) ◽

pp. 2034-2051 ◽

Cited By ~ 2

Author(s):

Samuel J. P. Malkin ◽

Monika Russel-Szymczyk ◽

Marek Psota ◽

Lucia Hlavinkova ◽

Barnaby Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis

Diabetic Medicine ◽

10.1111/dme.12366 ◽

2013 ◽

Vol 31 (5) ◽

pp. 615-623 ◽

Cited By ~ 10

Author(s):

C. B. Giorda ◽

A. Nicolucci ◽

F. Pellegrini ◽

C. K. Kristiansen ◽

B. Hunt ◽

...

Keyword(s):

Type 2 Diabetes ◽

Quality Of Care ◽

Cost Effectiveness ◽

PDB11 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF REPAGLINIDE + METFORMIN VERSUS NATEGLINIDE + METFORMIN IN TYPE 2 DIABETES PATIENTS WITH INADEQUATE GLYCEMIC CONTROL ON MONOTHERAPY: A FINNISH ANALYSIS

Value in Health ◽

10.1016/s1098-3015(10)64409-9 ◽

2006 ◽

Vol 9 (3) ◽

pp. A34 ◽

Cited By ~ 1

Author(s):

W Valentine ◽

V Munro ◽

AS Brandt ◽

J Ray ◽

S Roze ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Glycemic Control ◽

Effectiveness Analysis ◽

Inadequate Glycemic Control ◽

Diabetes Patients

PDB34 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF A MODERN INSULIN IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES IN THE GERMAN SETTING; DATA FROMTHE PREDICTIVE STUDY

Value in Health ◽

10.1016/s1098-3015(10)64982-0 ◽

2007 ◽

Vol 10 (6) ◽

pp. A264

Author(s):

JL Palmer ◽

G Goodall ◽

M Aagren ◽

S Nielsen ◽

R Kotchie ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Predictive Study

Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia

Diabetes Therapy ◽

10.1007/s13300-018-0542-x ◽

2018 ◽

Vol 10 (1) ◽

pp. 159-176 ◽

Cited By ~ 4

Author(s):

Samuel J. P. Malkin ◽

Monika Russel-Szymczyk ◽

Girtel Liidemann ◽

Vallo Volke ◽

Barnaby Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Once Daily ◽

PDB77 - LONG-TERM COST-EFFECTIVENESS ANALYSIS OF IDEGLIRA VERSUS IGLARLIXI FOR THE TREATMENT OF PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN IN THE ITALIAN SETTING

Value in Health ◽

10.1016/j.jval.2018.09.782 ◽

2018 ◽

Vol 21 ◽

pp. S131 ◽

Cited By ~ 2

Author(s):

R. Montagnoli ◽

G. Lastoria ◽

W. Parekh ◽

J. Pöhlmann ◽

B. Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Basal Insulin ◽